Marc Rubin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 43,326 shares at $6.02 ($261K) on 2019-02-21, disclosed to the SEC on 2019-02-25.
Open-market sale of $261k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTNP | BUY | 2018-09-25 | $100K | — | Filing → |
| GALT | SELL | 2018-09-06 | $78K | — | Filing → |
| GALT | SELL | 2018-09-04 | $353K | — | Filing → |